This inventor holds 1 USPTO granted patent. Top assignee: United Therapeutics Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Bryan Fioret and His Work on Endothelial Cell Barriers.
Introduction
Bryan Fioret is an inventor associated with Durham, North Carolina, and United Therapeutics Corporation. His patent work addresses methods and compositions intended to improve the vascular barrier formed by endothelial cells.
Latest Patents
Fioret is associated with 1 patent, titled “Methods and Compositions for Improving Endothelial Cell Barrier.” The patent describes approaches for strengthening endothelial cell barriers through barrier agonist compounds and improved cell-culturing techniques. These approaches may use an adenylyl cyclase activator, an activator of S1P receptor internalization, or agents that directly or indirectly promote tight-junction or adherens-junction protein expression.
Career Highlights
Fioret’s listed work connects biomedical research and patent innovation at United Therapeutics Corporation. The invention focuses on endothelial cell culture and vascular barrier function, areas relevant to research into vascular biology.
Collaborations
Thomas Petersen and Ryan Bonvillain are identified as Fioret’s coworkers. Their shared association with United Therapeutics Corporation provides professional context for his work.
Conclusion
Bryan Fioret’s patent highlights a practical approach to improving endothelial cell barriers through targeted compounds and refined cell-culturing methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
